Hanson & Doremus Investment Management’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$108K Sell
1,300
-355
-21% -$29.5K 0.01% 255
2025
Q1
$134K Sell
1,655
-1,924
-54% -$156K 0.02% 224
2024
Q4
$322K Sell
3,579
-1,346
-27% -$121K 0.05% 146
2024
Q3
$487K Sell
4,925
-2,877
-37% -$284K 0.08% 110
2024
Q2
$723K Sell
7,802
-1,107
-12% -$103K 0.12% 90
2024
Q1
$845K Sell
8,909
-4,697
-35% -$446K 0.15% 84
2023
Q4
$1.22M Sell
13,606
-9,706
-42% -$867K 0.23% 72
2023
Q3
$1.7M Sell
23,312
-544
-2% -$39.7K 0.35% 60
2023
Q2
$1.99M Buy
23,856
+1,534
+7% +$128K 0.41% 50
2023
Q1
$1.7M Buy
22,322
+351
+2% +$26.7K 0.38% 56
2022
Q4
$1.82M Buy
21,971
+1,885
+9% +$156K 0.39% 58
2022
Q3
$1.59M Buy
20,086
+4,468
+29% +$354K 0.41% 54
2022
Q2
$1.16M Buy
15,618
+2,405
+18% +$179K 0.28% 72
2022
Q1
$1.19M Buy
13,213
+1,472
+13% +$132K 0.26% 73
2021
Q4
$1.32M Buy
11,741
+1,094
+10% +$123K 0.28% 65
2021
Q3
$1.34M Buy
10,647
+2,055
+24% +$258K 0.31% 65
2021
Q2
$957K Sell
8,592
-760
-8% -$84.7K 0.29% 70
2021
Q1
$1.27M Buy
9,352
+530
+6% +$71.9K 0.29% 73
2020
Q4
$1.24M Buy
8,822
+230
+3% +$32.4K 0.31% 63
2020
Q3
$957K Buy
8,592
+1,461
+20% +$163K 0.29% 70
2020
Q2
$798K Sell
7,131
-93
-1% -$10.4K 0.25% 80
2020
Q1
$559K Buy
7,224
+1,606
+29% +$124K 0.19% 94
2019
Q4
$534K Buy
5,618
+1,259
+29% +$120K 0.15% 110
2019
Q3
$332K Buy
4,359
+4,230
+3,279% +$322K 0.1% 133
2019
Q2
$11K Buy
+129
New +$11K ﹤0.01% 411